Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk

Effects of Immunosuppression and Liver Transplantation on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis

(2013) Udayakumar Navaneethan et al.   Clinical Gastroenterology and Hepatology

Immunosuppression After Liver Transplantation for Primary Sclerosing Cholangitis Influences Activity of Inflammatory Bowel Disease

(2013) Kristin Kaasen Jørgensen et al.   Clinical Gastroenterology and Hepatology

Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis

(2013) Guru Trikudanathan et al.   GASTROINTESTINAL ENDOSCOPY

Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis

(2013) Udayakumar Navaneethan et al.   GASTROINTESTINAL ENDOSCOPY

The Presence of Primary Sclerosing Cholangitis Is Protective for Ileal Pouch from Crohnʼs Disease

(2013) Xian-rui Wu et al.   INFLAMMATORY BOWEL DISEASES

Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis

(2013) Udayakumar Navaneethan et al.   Journal of Crohns & Colitis

Update on primary sclerosing cholangitis

(2013) Tom H. Karlsen et al.   JOURNAL OF HEPATOLOGY

Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need for Colectomy in Patients With Ulcerative Colitis

(2012) Udayakumar Navaneethan et al.   Clinical Gastroenterology and Hepatology

Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease

(2012) Guru Trikudanathan et al.   DRUGS

Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis

(2012) Udayakumar Navaneethan et al.   GASTROINTESTINAL ENDOSCOPY

Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

(2012) David N. Abarbanel et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis

(2012) Udayakumar Navaneethan et al.   Journal of Crohns & Colitis

Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis

(2012) Udayakumar Navaneethan et al.   Journal of Crohns & Colitis

Impact of ileal pouch-anal anastomosis on the surgical outcome of orthotopic liver transplantation for primary sclerosing cholangitis

(2012) Emmanuel C. Obusez et al.   Journal of Crohns & Colitis

Bile acid transporters and regulatory nuclear receptors in the liver and beyond

(2012) Emina Halilbasic et al.   JOURNAL OF HEPATOLOGY

Improvement of serum alkaline phosphatase to

(2012) Said Al Mamari et al.   JOURNAL OF HEPATOLOGY

Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis

(2011) Jing Hieng Ngu et al.   Clinical Gastroenterology and Hepatology

Nuclear Receptors as New Perspective for the Management of Liver Diseases

(2011) Michael Trauner et al.   GASTROENTEROLOGY

Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis

(2011) Salvatore Modica et al.   GASTROENTEROLOGY

Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?

(2011) L. Marelli et al.   GUT

PSC: Protect and Serve with Colitis: does it help the liver to have severe ulcerative colitis?

(2011) C. Rust et al.   GUT

The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract

(2011) Serge J.L.B. Zweers et al.   HEPATOLOGY

Hepatobiliary disorders and complications of inflammatory bowel disease

(2011) Preethi GK VENKATESH et al.   Journal of Digestive Diseases

Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype

(2011) P. Rausch et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease

(2011) Carlos González-Juanatey et al.   ARTHRITIS RESEARCH & THERAPY

Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1

(2010) Vassilis Triantis et al.   HEPATOLOGY

Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity

(2010) Evaggelia Liaskou et al.   HEPATOLOGY

Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease

(2010) Dermot P.B. McGovern et al.   HUMAN MOLECULAR GENETICS

Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease

(2010) Udayakumar Navaneethan et al.   INFLAMMATORY BOWEL DISEASES

Primary sclerosing cholangitis is associated with endoscopic and histologic inflammation of the distal afferent limb in patients with ileal pouch–anal anastomosis

(2010) Bo Shen et al.   INFLAMMATORY BOWEL DISEASES

In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival

(2010) Gerda Rudolph et al.   JOURNAL OF HEPATOLOGY

Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis

(2009) Mee Joo et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Precancerous Bile Duct Pathology in End-stage Primary Sclerosing Cholangitis, With and Without Cholangiocarcinoma

(2009) Jason T. Lewis et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978–2003

(2009) Rune Erichsen et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

(2009) Keith D. Lindor et al.   HEPATOLOGY

Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis

(2009) Anna Lepistö et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Ulcerative colitis associated with IgG4 cholangitis: Similar features in two HLA identical siblings

(2009) Sergio Negrin Dastis et al.   JOURNAL OF HEPATOLOGY

Autoimmune Pancreatitis, Sclerosing Cholangitis, Liver Inflammatory Pseudotumors, Retroperitoneal Fibrosis, Lymphadenopathy, and Sialoadenitis in a Single Patient

(2009) Nicolas de Suray et al.   PANCREAS

Atypical p-ANCA in PSC and AIH: A Hint Toward a “leaky gut”?

(2008) Birgit Terjung et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

(2008) Frank G. Schaap et al.   HEPATOLOGY

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective

(2008) Susan N. Cullen et al.   JOURNAL OF HEPATOLOGY

High lifetime risk of cancer in primary sclerosing cholangitis

(2008) Marian M.H. Claessen et al.   JOURNAL OF HEPATOLOGY

Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation

(2008) Evangelos Cholongitas et al.   LIVER TRANSPLANTATION

Impact of Orthotopic Liver Transplant for Primary Sclerosing Cholangitis on Chronic Antibiotic Refractory Pouchitis

(2007) Katherine Freeman et al.   Clinical Gastroenterology and Hepatology